The trial (NCT06207370) evaluates tafenoquine combined with standard treatment for babesiosis, addressing a critical unmet medical need. The clinical site is led by Brigham and Women’s Hospital ...

On Tuesday, 60 Degrees Pharmaceuticals Inc (SXTP) stock saw a modest uptick, ending the day at $1.95 which represents a slight increase of $0.50 or 34.48% from the prior close of $1.45. The stock ...

ORLANDO, FL / ACCESSWIRE / November 22, 2024 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (Nasdaq:SXTP) and Can-Fite BioPharma Ltd. (NYSE American:CANF)(TASE ...

60 Degrees Pharmaceuticals (SXTP) has entered into a clinical trial agreement with Brigham and Women’s Hospital in Boston to conduct a double-blind, placebo-controlled study evaluating the ...

WASHINGTON, Dec. 11, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (60 Degrees Pharmaceuticals or the “Company”), a pharmaceutical company focused on ...

Degree Works is USU's degree-audit tool ... Below outlines a few of them, along with helpful links to the right. Your academic advisor is an important resource and partner in designing and tracking ...

WASHINGTON, Dec. 11, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (60 Degrees Pharmaceuticals or the “Company”), a pharmaceutical company focused on developing new ...

“If I were hiring somebody to be my right-hand person today ... "What are the best places to graduate with a bachelor's degree or master's degree in your preferred field?," ...

On Thursday, H.C. Wainwright maintained its Neutral stance on 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP), following the company's announcement on December 11 that it is expanding its clinical ...

In an exclusive interview, Geoffrey Dow, CEO and President of 60 Degrees Pharmaceuticals, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss the company's mission to ...